EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nutlin-3a-Mediated IL17RB Repression Leads to Enhanced p53 Responses via Modulating the Cellular Levels of p21 and Bcl-2

Alessandro Provvido, Can Sabancelebi, Shiva Shastri, Joseph Sachakov, Olivia Hu, Ivana Vancurova, Yan Zhu

Cells · 12.11.2026 · 15 (22) · 2066

DOI: 10.3390/cells15222066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 12.11.2026. Verfasst von Alessandro Provvido und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interleukin 17 (IL17) cytokine family and its receptors are essential to normal host immune function, and their dysregulation has been linked to a broad range of human diseases, most notably inflammatory conditions and cancer. Interleukin 17 receptor B (IL17RB), in particular, has emerged as an important contributor to tumorigenesis. Here we identified IL17RB as a target of p53-mediated repression. Nutlin-3a treatment substantially decreased IL17RB expression across several cell lines harboring wild-type p53, but not in mutant-p53 or p53-null lines, and the effect was not reversed by proteasome inhibition. Depletion of either p53 or p21 partially rescued IL17RB expression. Functionally, IL17RB depletion enhanced, whereas IL17RB overexpression attenuated, nutlin-3a-induced inhibition of cell proliferation and migration. In line with this, IL17RB knockdown increased, while IL17RB overexpression reduced, nutlin-3a-induced p21 expression. IL17B treatment attenuated nutlin-3a-mediated p21 induction and Bcl-2 repression. Bioinformatic analysis showed that IL17RB expression was higher in prostate and colon tumors than in their respective matched normal tissue. Interestingly, IL17RB correlated modestly but significantly with Bcl-2 and inversely with p21 in colon tumors. Collectively, these findings indicate that p53-dependent repression of IL17RB reinforces p53 responses, revealing a functional connection between inflammatory signaling and p53-dependent tumor suppression.

Förderung

  • National Institutes of Health

Zitieren

APA

Provvido, A., Sabancelebi, C., Shastri, S., Sachakov, J., Hu, O., Vancurova, I., & Zhu, Y. (2026). Nutlin-3a-Mediated IL17RB Repression Leads to Enhanced p53 Responses via Modulating the Cellular Levels of p21 and Bcl-2. Cells, 15(22), 2066. https://doi.org/10.3390/cells15222066

Vancouver

Provvido A, Sabancelebi C, Shastri S, Sachakov J, Hu O, Vancurova I, et al. Nutlin-3a-Mediated IL17RB Repression Leads to Enhanced p53 Responses via Modulating the Cellular Levels of p21 and Bcl-2. Cells. 2026;15(22):2066. doi:10.3390/cells15222066

BibTeX
@article{Provvido2026,
  author = {Provvido, Alessandro and Sabancelebi, Can and Shastri, Shiva and Sachakov, Joseph and Hu, Olivia and Vancurova, Ivana and Zhu, Yan},
  title = {Nutlin-3a-Mediated IL17RB Repression Leads to Enhanced p53 Responses via Modulating the Cellular Levels of p21 and Bcl-2},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {2066},
  doi = {10.3390/cells15222066}
}
Kostenlos starten →